1. Home
  2. CRNX vs CALX Comparison

CRNX vs CALX Comparison

Compare CRNX & CALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • CALX
  • Stock Information
  • Founded
  • CRNX 2008
  • CALX 1999
  • Country
  • CRNX United States
  • CALX United States
  • Employees
  • CRNX N/A
  • CALX N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • CALX Telecommunications Equipment
  • Sector
  • CRNX Health Care
  • CALX Consumer Discretionary
  • Exchange
  • CRNX Nasdaq
  • CALX Nasdaq
  • Market Cap
  • CRNX 2.8B
  • CALX 2.9B
  • IPO Year
  • CRNX 2018
  • CALX 2010
  • Fundamental
  • Price
  • CRNX $30.40
  • CALX $59.41
  • Analyst Decision
  • CRNX Strong Buy
  • CALX Buy
  • Analyst Count
  • CRNX 7
  • CALX 4
  • Target Price
  • CRNX $74.33
  • CALX $62.33
  • AVG Volume (30 Days)
  • CRNX 1.0M
  • CALX 605.9K
  • Earning Date
  • CRNX 08-07-2025
  • CALX 10-27-2025
  • Dividend Yield
  • CRNX N/A
  • CALX N/A
  • EPS Growth
  • CRNX N/A
  • CALX N/A
  • EPS
  • CRNX N/A
  • CALX N/A
  • Revenue
  • CRNX $1,392,000.00
  • CALX $869,193,000.00
  • Revenue This Year
  • CRNX $489.51
  • CALX $17.53
  • Revenue Next Year
  • CRNX $661.93
  • CALX $10.10
  • P/E Ratio
  • CRNX N/A
  • CALX N/A
  • Revenue Growth
  • CRNX 0.51
  • CALX N/A
  • 52 Week Low
  • CRNX $24.10
  • CALX $28.61
  • 52 Week High
  • CRNX $62.53
  • CALX $59.84
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 53.04
  • CALX 65.98
  • Support Level
  • CRNX $28.73
  • CALX $58.05
  • Resistance Level
  • CRNX $31.70
  • CALX $59.18
  • Average True Range (ATR)
  • CRNX 1.29
  • CALX 1.50
  • MACD
  • CRNX 0.25
  • CALX 0.01
  • Stochastic Oscillator
  • CRNX 77.85
  • CALX 88.86

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About CALX Calix Inc

Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.

Share on Social Networks: